Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma

Carbon monoxide is a product of haem degradation by haem oxygenase (HO), activated by inflammatory cytokines and oxidants. This study examined whether allergen challenge can increase exhaled CO levels, as a reflection of HO activation. Exhaled CO and nitric oxide, an expired gas also thought to reflect cytokine-induced airway inflammation, were measured in 15 atopic steroid-naive nonsmoking patients with asthma (13 males, aged 30+/-2 yrs) before and for up to 20 h after allergen challenge. Baseline CO (4.4+/-0.3 parts per million (ppm)) and NO (20.6+/-1.2 parts per billion (ppb)) levels were elevated in asthmatic as compared with nonsmoking normal volunteers (n = 37, 2.1+/-0.2 ppm and 7.0+/-0.1 ppb, respectively, p<0.05). In 10 patients with a dual response in the forced expiratory volume in one second (FEV1) there was a maximal increase in exhaled CO at 1 h (343+/-7.1%) and at 6 h (69+/-12%, p<0.01), followed by a maximal fall in FEV1 (28+/-9%, p<0.05) at 9 h, whereas the maximal NO increase was observed at 10 h (50.2+/-11.8%). The maximal increase in exhaled CO in single response patients (n = 5) was 30+/-2% during the early asthmatic reaction and 46.3+/-9.2% between 4 and 10 h, followed by a fall in FEV1 (9+/-3%, p>0.05) at 9 h, whereas exhaled NO was not significantly changed. In five patients exhaled CO was not attenuated by inhalation of increasing concentrations of histamine causing a 20% fall in FEV1 (PC20) or its subsequent relief by beta2-agonists. In conclusion, exhaled carbon monoxide is increased during the early and late asthmatic reactions independently of the change in airway calibre, while exhaled nitric oxide is increased only during the late reaction and follows the increase in carbon monoxide and fall in the forced expiratory volume in one second in time.

This article has been cited by other articles:

				L. E. Fredenburgh, M. A. Perrella, and S. A. Mitsialis The Role of Heme Oxygenase-1 in Pulmonary Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 158 - 165. [Abstract] [Full Text] [PDF]

				H. J. Stark, J. T. Randell, M-R. Hirvonen, M. K. Purokivi, M. H. Roponen, and H. O. Tukiainen The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels Eur. Respir. J., November 1, 2005; 26(5): 887 - 893. [Abstract] [Full Text] [PDF]

				D. Morse and A. M. K. Choi Heme Oxygenase-1: From Bench to Bedside Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 660 - 670. [Abstract] [Full Text] [PDF]

				G. M. King Uptake of Carbon Monoxide and Hydrogen at Environmentally Relevant Concentrations by Mycobacteria{dagger} Appl. Envir. Microbiol., December 1, 2003; 69(12): 7266 - 7272. [Abstract] [Full Text] [PDF]

				P. Paredi, S. A. Kharitonov, and P. J. Barnes Analysis of Expired Air for Oxidation Products Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S31 - 37. [Abstract] [Full Text] [PDF]

				R. Piipari, P. Piirila, H. Keskinen, M. Tuppurainen, A. Sovijarvi, and H. Nordman Exhaled nitric oxide in specific challenge tests to assess occupational asthma Eur. Respir. J., December 1, 2002; 20(6): 1532 - 1537. [Abstract] [Full Text] [PDF]

				W. Zetterquist, H. Marteus, M. Johannesson, S.L. Nordvall, E. Ihre, J.O.N. Lundberg, and K. Alving Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Eur. Respir. J., July 1, 2002; 20(1): 92 - 99. [Abstract] [Full Text] [PDF]

				J.O.N. Lundberg, J. Palm, and K. Alving Nitric oxide but not carbon monoxide is continuously released in the human nasal airways Eur. Respir. J., July 1, 2002; 20(1): 100 - 103. [Abstract] [Full Text] [PDF]

				C Ward, M Pais, R Bish, D Reid, B Feltis, D Johns, and E H Walters Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax, April 1, 2002; 57(4): 309 - 316. [Abstract] [Full Text] [PDF]

				S. B. KHATRI, M. OZKAN, K. MCCARTHY, D. LASKOWSKI, J. HAMMEL, R. A. DWEIK, and S. C. ERZURUM Alterations in Exhaled Gas Profile during Allergen-induced Asthmatic Response Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1844 - 1848. [Abstract] [Full Text] [PDF]

				I. Horvath, W. MacNee, F.J. Kelly, P.N.R. Dekhuijzen, M. Phillips, G. Doring, A.M.K. Choi, M. Yamaya, F.H. Bach, D. Willis, et al. "Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999 Eur. Respir. J., August 1, 2001; 18(2): 420 - 430. [Abstract] [Full Text] [PDF]

				J. T. Chapman, L. E. Otterbein, J. A. Elias, and A. M. K. Choi Carbon monoxide attenuates aeroallergen-induced inflammation in mice Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L209 - L216. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				P. PAREDI, S. A. KHARITONOV, D. LEAK, S. WARD, D. CRAMER, and P. J. BARNES Exhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 369 - 373. [Abstract] [Full Text] [PDF]

				P. PAREDI, S. A. KHARITONOV, D. LEAK, P. L. SHAH, D. CRAMER, M. E. HODSON, and P. J. BARNES Exhaled Ethane Is Elevated in Cystic Fibrosis and Correlates with Carbon Monoxide Levels and Airway Obstruction Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1247 - 1251. [Abstract] [Full Text]